| Patent Number |
Title Of Patent |
Date Issued |
| 7371723 |
Therapeutic agents comprising pro-apoptotic proteins |
May 13, 2008 |
| The present invention relates to targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor. In a preferred embodiment, the signal transduction pathway factor is an apoptosis-inducing factor, such as |
| 7101977 |
Therapeutic agents comprising pro-apoptotic proteins |
September 5, 2006 |
| The present invention relates to targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor. In a preferred embodiment, the signal transduction pathway factor is an apoptosis-inducing factor, such as |
| 4150042 |
6-Hydroxy-7-methoxy-5-benzofuran carboxaldehyde and 2,3-dihydro-7-methoxy-6-benzofuranol |
April 17, 1979 |
| The invention relates to synthetic processes to produce the known pharmacologically active 9-methoxypsoralen. Also disclosed are various novel intermediates utilized in these processes. |
| 4147703 |
Process to produce 8-methoxypsoralen |
April 3, 1979 |
| The invention relates to synthetic processes to produce the known pharmacologically active 9-methoxypsoralen. Also disclosed are various novel intermediates utilized in these processes. |
| 4107182 |
7-Oxo-9-methoxy-7H-furo[3,2-g][1]benzopyran-6-carboxylic acid |
August 15, 1978 |
| The invention relates to synthetic processes to produce the known pharmacologically active 9-methoxypsoralen. Also disclosed are various novel intermediates utilized in these processes. |
